Skip to main content
Year archive

ALTERITY THERAPEUTICS LIMITED — 2026 filings

All 31 regulatory filings released by ALTERITY THERAPEUTICS LIMITED (ATH) in 2026, sourced directly from the official regulator.

31 Filings
2026 Period
2026 filings (31)
Filing Released Lang
Alterity Data Supports ATH434 Phase 3 Advancement in MSA 6 pages 275.7KB
Regulatory Filings
2026-05-18 English
Corporate Presentation May 2026 46 pages 3.4MB
Investor Presentation
2026-05-11 English
Alterity Announces Publication on MRI as Biomarker for MSA 5 pages 251.3KB
Regulatory Filings
2026-05-10 English
Alterity to Deliver Presentations at May Medical Meetings 3 pages 215.6KB
Investor Presentation
2026-05-06 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 449.2KB
Interim / Quarterly Report
2026-04-29 English
Consolidation/Split - ATH 10 pages 33.1KB
Share Issue/Capital Change
2026-04-29 English
Notice of General Meeting/Proxy Form 29 pages 713.4KB
Proxy Solicitation & Information Statement
2026-04-28 English
Alterity Receives Positive FDA Feedback on CMC Meeting 3 pages 189.7KB
Regulatory Filings
2026-04-26 English
Change in substantial holding 6 pages 351.8KB
Major Shareholding Notification
2026-04-23 English
Alterity Presents New Analysis of ATH434 Phase 2 Data at AAN 4 pages 228.0KB
Regulatory Filings
2026-04-21 English
Initial Director's Interest Notice - Cunningham 2 pages 251.2KB
Director's Dealing
2026-04-20 English
Notification regarding unquoted securities - ATH 8 pages 21.9KB
Share Issue/Capital Change
2026-04-19 English
Notification regarding unquoted securities - ATH 8 pages 21.9KB
Share Issue/Capital Change
2026-04-19 English
Alterity Appoints Biotech Executive Ann Cunningham to Board 3 pages 190.4KB
Board/Management Information
2026-04-16 English
Alterity Announces Late-Breaker Oral Presentation at AAN 3 pages 184.6KB
Regulatory Filings
2026-04-15 English
Alterity to Host KOL Event to Share New Insights on ATH434 4 pages 223.0KB
Regulatory Filings
2026-04-14 English
Corporate Presentation April 2026 39 pages 1.9MB
Investor Presentation
2026-03-31 English
Alterity Receives Positive FDA Feedback From Type C Meeting 3 pages 187.0KB
Regulatory Filings
2026-03-29 English
Notification regarding unquoted securities - ATH 8 pages 21.8KB
Share Issue/Capital Change
2026-03-25 English
Proposed issue of securities - ATH 5 pages 18.8KB
Capital/Financing Update
2026-03-18 English
Unmarketable Parcel Sale Facility 8 pages 527.9KB
Capital/Financing Update
2026-03-11 English
Alterity to Participate in the Bell Potter Healthcare Summit 2 pages 182.2KB
Regulatory Filings
2026-03-08 English
Dr Daniel Claassen as Chief Medical Advisor 3 pages 190.2KB
Board/Management Information
2026-03-03 English
Half Yearly Report and Accounts 27 pages 1.6MB
Regulatory Filings
2026-02-25 English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 496.4KB
Interim / Quarterly Report
2026-01-29 English
ATH Shareholder Letter January 2026 5 pages 247.7KB
Management Reports
2026-01-20 English
Notification regarding unquoted securities - ATH 6 pages 19.6KB
Share Issue/Capital Change
2026-01-14 English
Notification regarding unquoted securities - ATH 6 pages 19.6KB
Share Issue/Capital Change
2026-01-14 English
Corporate Presentation 37 pages 2.3MB
Investor Presentation
2026-01-12 English
Notification of cessation of securities - ATH 5 pages 16.1KB
Share Issue/Capital Change
2026-01-06 English
Change of Director's Interest Notice - D Stamler 3 pages 938.4KB
Regulatory Filings
2026-01-06 English